Entries tagged "AbbVie"

You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "AbbVie."

6 result(s) displayed (1 - 6 of 6)

AbbVie gains its independence

More than a year after announcing that it would split off from Abbott Laboratories, the research-based pharmaceutical company's stock finally started trading Wednesday. Continue reading

Posted on January 2, 2013 3:45 PM

William Chase on Abbott's M&A strategy

Abbott's VP of licensing and acquisitions discuss the pharmaceutical giant's acquisition strategy as it prepares to split into two different companies at the start of 2013. Continue reading

Posted on November 19, 2012 1:04 PM

Breaking up

After years of being a top dealmaker, Abbott is doing its biggest deal yet as it breaks itself in two. Continue reading

Posted on November 19, 2012 12:15 PM

AstraZeneca's halted buyback raises M&A hopes

Analysts speculate that the U.K. pharma giant will use the cash instead to make a deal to help mitigate its pipeline development and generic competition challenges. Continue reading

Posted on October 3, 2012 9:05 AM

Analyst urges Roche back to acquisition trail

Jefferies & Co.'s Jeffrey Holford identifies a few potential targets for the Swiss pharma giant, but while other analysts agree an earnings slide is coming, they don't share his M&A yearning. Continue reading

Posted on September 27, 2012 4:01 PM

Abbott continues to prep for new focus

The healthcare conglomerate acquires a kidney disease compound from Action Pharma for $110 million. Continue reading

Posted on May 3, 2012 3:48 PM

Movable Type search results powered by Fast Search